MyAverix Finance
SHG · Healthcare
Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221)
Drug Manufacturers - Specialty & Generic
Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688221
Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221) — FAQ
What is 688221's P/E ratio?
The price-to-earnings (P/E) ratio for Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221) is 18.00 (data as of 2026-05-24).
Does Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221). Check the MyAverix Finance app for the latest dividend data.
What sector is Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A in?
Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 688221 listed on?
688221 is listed on SHG.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.